Knight Campus Grants
PI | Sponsor | title | cumulative amount | dates of project | expenditures as of 1/5/2022 |
---|---|---|---|---|---|
Ambati | Utah/NIH | Sustained Intravitreal Delivery of Ranibizumab Mediated by ECM Binding | $81,194.00 | 9/30/21 - 6/30/21 | $54,134.96 |
Ambati | NIH | Neurovascular Cross-talk, Functions and Sources of Soluble VEGF Receptors in Ocular Vascular Demarcation | $688,081.00 | 10/3/20 - 3//31/22 |
$498,076.03 |
Ambati | NIH/UVA | DICER1 Deficiency in Aberrant Chorioretinal Neovascularization | $183,536.00 | 6/1/21 - 5/31/22 | $20,623.26 |
Zhang/Ambati | Fight for Sight | A Topical Dopamine Agonist Pergolide Relieves Chronic Ocular Pain in the Mouse Model | $22,500.00 | 9/20/21 - 9/19/22 | $459.89 |
Dalton | Industry Sponsored | Manufacturing of a Product | $52,149.00 | 10/1/21 - 12/31/21 | $0.00 |
Gardner | Duke/NIH | Corticostriatal Contributions to Motor Exploration and Reinforcement | $916,241.00 | 9/30/20 - 8/31/23 | $313,001.24 |
Gardner | Cal Tech/NIH | The Self-Tuning Brain: Cellular and Circuit Mechanisms of Behavioral Resilience | $1,106,250.00 | 12/1/19 - 11/30/22 | $623,089.09 |
Guldberg | OHSU/NIH |
Microengineering vascularized and innervated bone-likescaffolds as an alternative to autologous bone grafts |
$945.845.00 | 8/1/21 - 4/30/26 | $0.00 |
Guldberg | NIH | Mechanical Regulation of Vascular Growth and Remodeling | $1,376,771.25 | 8/26/18 - 3/31/21 | $1,376,126.93 |
Guldberg | ReMDO/DOD | Support of the Medical Technology Enterprise Consortium (MTEC) Research, Development, Production and Commercialization Efforts | $600,000.00 | 9/1/19 - 10/31/21 | $515,466.32 |
Guldberg | State of Oregon/URIF | Cost Share for ReMDO: Support of the Medical Technology Enterprise Consortium (MTEC) Research, Development, Production and Commercialization Efforts | $600,000.00 | 9/1/19 - 10/31/21 | $599,717.36 |
Guldberg | NIH | Immunoengineering Strategies for Musculoskeletal Trauma | $2,506,375.00 | 5/1/20 - 4/30/25 | $831,868.02 |
Guldberg | PeaceHealth | Center for Translational Biomedical Research | $512,400.00 | 10/5/20 - 10/4/23 | $33,075.84 |
Hettiaratchi | DOD |
Affinity-Controlled Co-Delivery of Immunomodulatory and Osteogenic Proteins to Enhance Bone Repair |
$295,000.00 | 3/1/22 - 2/28/24 | $0.00 |
Hettiaratchi | NIH - R21 | A Direct Evolution Approach to Affinity-Based Protein Delivery [R21] | $602,165.00 | 9/1/21 - 5/31/22 | $15,543.28 |
Hettiaratchi | Medical Research Fund | Affinity-based Biomaterials to Enhance Tissue Vascularization | $50,000 | 3/1/21 - 2/28/22 |
$16,943.84 |
Hettiaratchi | Collins Med. Trust | Development of a Biomaterial Strategy to Control Bone Morphogenetic Protein-2 (BMP-2) Delivery for Bone Repair | $29,880.00 | 9/1/20 - 3/31/22 | $22,457.63 |
Hosseinzadeh | NIH/DP2 | A Data-Driven Approach Towards Generation of Permeable Peptide Therapeutics | $1,301,850.00 | 9/22/21 - 8/31/24 | $0.00 |
Ong | University of Arkansas/NSF |
Biophysical Modulation for Scalable Biomanufacturing of Stem Cell-Derived Therapeutics |
$100,000.00 | 1/1/22 - 12/31/23 | $0.00 |
Ong | Penderia/NIH |
NIH-SBIR: Sensorized Suture Buttons for Tracking Force Loading at Anterior Cruciate Ligament Repair |
$49,199.00 | 7/1/21 - 11/30/22 | $829.69 |
Ong | Georgia Tech/NSF | Center for Advanced Cell Manufacturing | $738,002.00 | 10/1/18 - 9/30/22 | $465,758.04 |
Ong | DOD | Accelerating early-stage bone regeneration with Lorentz force-driven interstitial fluid flow | $295,000.00 | 3/1/21 - 2/28-23 |
$117,129.97 |
Plesa | Burroughs Wellcome Fund | Ubiquitous Biosensing through Engineered Histidine Kinases | $430,000.00 | 7/1/19 - 6/30/23 | $223,607.44 |
Plesa | Columbia Univ./NSF | Towards Life with a Reduced Protein Alphabet | $450,000.00 | 8/1/20 - 8/31/23 | $53,710.74 |
Plesa | NIH/DP2 | DP2 - Proteome Scale Multiplexed Generation of Recombinant Antibodies | $1,295,675.00 | 9/10/21 - 5/31/24 | $4,543.16 |
Plesa | Industry Sponsor | DropSynth Methodology to Create Libraries of DNA Sequences | $138,000.00 | 7/1/21 - 9/22/22 | $44,441.00 |
Reeder | Collins Medical Trust | Thermal Management of Implantable Nerve Coolers for Cooling-Induced Local Analgesia | $20,000.00 | 10/1/21 - 9/30/22 | $0.00 |
Willett | GIT/NIH |
Promoting Endogenous Cell Recruitment for Rotator Cuff Muscle Repair |
$14,037.00 | 9/21/21 - 8/31/22 | $0.00 |
Willett | GIT/NIH |
Biomaterials to enhance the efficacy of MSCs for rotator cuff repair |
$57,094.00 | 7/1/21 - 4/30/26 | $0.00 |
Willet | NIH | Engineering the Immune and Fibrotic Response in Volumetric Muscle Loss | $1,646,502.00 | 9/16/21 - 8/31/22 | $0.00 |
Total: | $15,212,194.25 | $4,944,308.35 |
UPDATED: January 2022